Robert Kratzke, MD, calls for a national biomarker testing mandate, emphasizing that timely genomic testing is essential for precision lung cancer care. In part 2 of an interview with The American ...
In 2013, Angelina Jolie inspired a wave of testing for pathogenic variants of the gene BRCA1 by announcing that she carried a ...
Radiation therapy remains a central modality in cancer treatment, but normal-tissue toxicity and long-term stochastic effects ...
Prostate cancer, the disease that killed my father when I was 11 years old, the disease that afflicts one in eight men, one ...
(NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces newly published data from the largest individual-patient-data meta-analysis of Prolaris to date, ...
The Queen Zone on MSN
New blood test could help spot aggressive prostate cancer earlier
For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...
Prostate cancer is the most common cancer among men after skin cancer, according to the American Cancer Society.
Caribbean men are to benefit from research into prostate cancer first carried out in Bermuda. The Caribbean Prostate Cancer ...
A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the ...
A next-generation Stockholm3 blood test detected aggressive prostate cancer more accurately than PSA, improving early ...
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results